Sodium in PDB 3zpr: Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
Protein crystallography data
The structure of Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound, PDB code: 3zpr
was solved by
J.A.Christopher,
M.Congreve,
A.S.Dore,
F.H.Marshall,
D.G.Myszka,
J.Brown,
M.Koglin,
B.Tehan,
J.C.Errey,
C.G.Tate,
T.Warne,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
95.55 /
2.70
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
89.968,
60.812,
101.178,
90.00,
109.20,
90.00
|
R / Rfree (%)
|
22.4 /
26.6
|
Sodium Binding Sites:
The binding sites of Sodium atom in the Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
(pdb code 3zpr). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 4 binding sites of Sodium where determined in the
Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound, PDB code: 3zpr:
Jump to Sodium binding site number:
1;
2;
3;
4;
Sodium binding site 1 out
of 4 in 3zpr
Go back to
Sodium Binding Sites List in 3zpr
Sodium binding site 1 out
of 4 in the Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1
b:53.8
occ:1.00
|
O
|
A:HOH2003
|
2.4
|
57.4
|
1.0
|
O
|
A:HOH2001
|
2.4
|
42.4
|
1.0
|
OD1
|
A:ASP87
|
2.4
|
48.0
|
1.0
|
O
|
A:HOH2002
|
2.5
|
57.3
|
1.0
|
OG
|
A:SER128
|
2.5
|
43.2
|
1.0
|
CB
|
A:SER128
|
3.4
|
37.2
|
1.0
|
CG
|
A:ASP87
|
3.5
|
49.7
|
1.0
|
O
|
A:HOH2004
|
3.8
|
57.7
|
1.0
|
OD2
|
A:ASP87
|
3.9
|
56.8
|
1.0
|
OD1
|
A:ASN335
|
3.9
|
46.3
|
1.0
|
OG
|
A:SER336
|
4.0
|
41.7
|
1.0
|
CE2
|
A:PHE299
|
4.1
|
41.2
|
1.0
|
O
|
A:HOH2017
|
4.3
|
38.2
|
1.0
|
O
|
A:HOH2018
|
4.5
|
58.0
|
1.0
|
CD2
|
A:PHE299
|
4.6
|
39.9
|
1.0
|
O
|
A:CYS124
|
4.7
|
40.7
|
1.0
|
CA
|
A:SER128
|
4.7
|
35.7
|
1.0
|
CB
|
A:ALA86
|
4.7
|
38.9
|
1.0
|
CB
|
A:ASP87
|
4.7
|
45.4
|
1.0
|
N
|
A:ASP87
|
4.8
|
43.4
|
1.0
|
CA
|
A:ASP87
|
4.8
|
44.4
|
1.0
|
O
|
A:LEU83
|
5.0
|
45.8
|
1.0
|
|
Sodium binding site 2 out
of 4 in 3zpr
Go back to
Sodium Binding Sites List in 3zpr
Sodium binding site 2 out
of 4 in the Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na2
b:57.8
occ:1.00
|
O
|
A:CYS198
|
2.4
|
49.8
|
1.0
|
O
|
A:ASP195
|
2.4
|
63.0
|
1.0
|
O
|
A:HOH2005
|
2.4
|
50.0
|
1.0
|
O
|
A:CYS192
|
2.4
|
63.4
|
1.0
|
O
|
A:TYR193
|
3.4
|
55.9
|
1.0
|
C
|
A:ASP195
|
3.5
|
68.2
|
1.0
|
C
|
A:CYS198
|
3.5
|
49.8
|
1.0
|
C
|
A:CYS192
|
3.6
|
67.3
|
1.0
|
C
|
A:TYR193
|
3.8
|
64.0
|
1.0
|
CA
|
A:TYR193
|
3.8
|
64.1
|
1.0
|
CB
|
A:CYS198
|
4.1
|
53.4
|
1.0
|
CA
|
A:CYS198
|
4.2
|
52.9
|
1.0
|
N
|
A:TYR193
|
4.2
|
65.1
|
1.0
|
N
|
A:CYS198
|
4.3
|
50.6
|
1.0
|
N
|
A:ASP195
|
4.3
|
72.4
|
1.0
|
SG
|
A:CYS192
|
4.3
|
70.8
|
1.0
|
N
|
A:PRO196
|
4.3
|
67.9
|
1.0
|
CA
|
A:PRO196
|
4.4
|
65.0
|
1.0
|
CA
|
A:ASP195
|
4.4
|
68.5
|
1.0
|
N
|
A:CYS199
|
4.6
|
53.3
|
1.0
|
C
|
A:PRO196
|
4.6
|
60.4
|
1.0
|
C
|
A:GLN194
|
4.7
|
73.4
|
1.0
|
N
|
A:GLN194
|
4.7
|
73.6
|
1.0
|
CA
|
A:CYS192
|
4.7
|
67.9
|
1.0
|
O
|
A:PRO196
|
4.8
|
62.4
|
1.0
|
CB
|
A:ASP195
|
4.9
|
69.3
|
1.0
|
CA
|
A:CYS199
|
4.9
|
51.5
|
1.0
|
SG
|
A:CYS198
|
5.0
|
63.8
|
1.0
|
|
Sodium binding site 3 out
of 4 in 3zpr
Go back to
Sodium Binding Sites List in 3zpr
Sodium binding site 3 out
of 4 in the Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 3 of Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na1
b:52.8
occ:1.00
|
OD1
|
B:ASP87
|
2.3
|
49.7
|
1.0
|
OG
|
B:SER128
|
2.4
|
43.6
|
1.0
|
O
|
B:HOH2002
|
2.4
|
40.2
|
1.0
|
O
|
B:HOH2003
|
2.5
|
55.6
|
1.0
|
CG
|
B:ASP87
|
3.4
|
52.6
|
1.0
|
CB
|
B:SER128
|
3.5
|
40.0
|
1.0
|
O
|
B:HOH2001
|
3.6
|
44.5
|
1.0
|
OG
|
B:SER336
|
3.8
|
43.4
|
1.0
|
OD2
|
B:ASP87
|
3.9
|
52.4
|
1.0
|
OD1
|
B:ASN335
|
4.3
|
38.8
|
1.0
|
O
|
B:HOH2016
|
4.3
|
34.9
|
1.0
|
CE2
|
B:PHE299
|
4.4
|
37.2
|
1.0
|
O
|
B:CYS124
|
4.4
|
41.4
|
1.0
|
CB
|
B:ALA86
|
4.5
|
41.2
|
1.0
|
N
|
B:ASP87
|
4.5
|
47.1
|
1.0
|
O
|
B:HOH2017
|
4.6
|
63.0
|
1.0
|
CA
|
B:ASP87
|
4.6
|
47.6
|
1.0
|
CB
|
B:ASP87
|
4.6
|
47.0
|
1.0
|
C
|
B:ALA86
|
4.7
|
44.9
|
1.0
|
CA
|
B:SER128
|
4.8
|
37.8
|
1.0
|
CD2
|
B:PHE299
|
4.9
|
38.3
|
1.0
|
O
|
B:LEU83
|
4.9
|
46.4
|
1.0
|
CB
|
B:SER336
|
5.0
|
41.8
|
1.0
|
O
|
B:ALA86
|
5.0
|
50.3
|
1.0
|
|
Sodium binding site 4 out
of 4 in 3zpr
Go back to
Sodium Binding Sites List in 3zpr
Sodium binding site 4 out
of 4 in the Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound
 Mono view
 Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 4 of Thermostabilised Turkey BETA1 Adrenergic Receptor with 4-Methyl-2- (Piperazin-1-Yl) Quinoline Bound within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Na2
b:57.8
occ:1.00
|
O
|
B:CYS198
|
2.4
|
54.2
|
1.0
|
O
|
B:CYS192
|
2.4
|
58.7
|
1.0
|
O
|
B:HOH2004
|
2.4
|
54.5
|
1.0
|
O
|
B:ASP195
|
2.5
|
57.4
|
1.0
|
O
|
B:TYR193
|
3.4
|
68.2
|
1.0
|
C
|
B:ASP195
|
3.5
|
58.2
|
1.0
|
C
|
B:CYS198
|
3.5
|
56.9
|
1.0
|
C
|
B:CYS192
|
3.5
|
60.2
|
1.0
|
C
|
B:TYR193
|
3.8
|
59.2
|
1.0
|
CA
|
B:TYR193
|
3.8
|
58.4
|
1.0
|
CB
|
B:CYS198
|
4.1
|
62.3
|
1.0
|
CA
|
B:CYS198
|
4.2
|
61.2
|
1.0
|
N
|
B:TYR193
|
4.2
|
57.2
|
1.0
|
N
|
B:ASP195
|
4.2
|
62.5
|
1.0
|
N
|
B:CYS198
|
4.3
|
59.1
|
1.0
|
SG
|
B:CYS192
|
4.3
|
72.3
|
1.0
|
N
|
B:PRO196
|
4.4
|
59.2
|
1.0
|
CA
|
B:PRO196
|
4.4
|
58.1
|
1.0
|
CA
|
B:ASP195
|
4.4
|
60.4
|
1.0
|
C
|
B:PRO196
|
4.6
|
55.0
|
1.0
|
N
|
B:CYS199
|
4.7
|
53.5
|
1.0
|
CA
|
B:CYS192
|
4.7
|
63.7
|
1.0
|
N
|
B:GLN194
|
4.7
|
62.5
|
1.0
|
O
|
B:PRO196
|
4.8
|
52.6
|
1.0
|
CB
|
B:ASP195
|
4.9
|
61.5
|
1.0
|
CA
|
B:CYS199
|
4.9
|
55.5
|
1.0
|
SG
|
B:CYS198
|
5.0
|
70.7
|
1.0
|
|
Reference:
J.Christopher,
J.Brown,
A.Dore,
J.Errey,
M.Koglin,
F.H.Marshall,
D.Myszka,
R.L.Rich,
C.G.Tate,
B.Tehan,
T.Warne,
M.Congreve.
Biophysical Fragment Screening of the BETA1-Adrenergic Receptor: Identification of High Affinity Aryl Piperazine Leads Using Structure-Based Drug Design. J.Med.Chem. V. 56 3446 2013.
ISSN: ISSN 0022-2623
PubMed: 23517028
DOI: 10.1021/JM400140Q
Page generated: Mon Oct 7 14:08:55 2024
|